AstraZeneca Pharma India Limited (BOM:506820)
India · Delayed Price · Currency is INR 6,517.85
-71.05 (-1.08%)
At close: Sep 25, 2026
AstraZeneca Pharma India Market Cap
AstraZeneca Pharma India has a market cap or net worth of 162.95 billion as of September 25, 2026. Its market cap has decreased by -25.98% in one year.
Market Cap
162.95B
Enterprise Value
159.58B
Revenue
24.32B
Ranking
n/a
PE Ratio
96.07
Stock Price
6,517.85
ChartMarket Cap Chart
Since February 27, 2002, AstraZeneca Pharma India's market cap has increased from 1.45B to 162.95B, an increase of 11,137.67%. That is a compound annual growth rate of 21.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 162.95B | -27.66% |
| Dec 31, 2025 | 225.25B | 23.26% |
| Dec 31, 2024 | 182.75B | 32.43% |
| Dec 29, 2023 | 138.00B | 67.65% |
| Dec 30, 2022 | 82.31B | 6.20% |
| Dec 31, 2021 | 77.51B | -32.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 477.19B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 215.92B |
| Caplin Point Laboratories | 215.55B |
| Jubilant Pharmova | 170.13B |
| Viyash Scientific | 106.69B |
| Procter & Gamble Health | 89.87B |
| Bliss GVS Pharma | 75.38B |